Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer: phase II study
- Author
- VALAVAARA, R1 ; PYRHONEN, S; HEIKKINEN, M; RISSANEN, P; BLANCO, G; THOLIX, E; NORDMAN, E; TASKINEN, P; HOLSTI, L; HAJBA, A
[1] Oulu univ. cent. hosp., dep. radiotherapy, Oulu, Finland - Source
European journal of cancer & clinical oncology. 1988, Vol 24, Num 4, pp 785-790 ; ref : 21 ref
- CODEN
- EJCODS
- ISSN
- 0277-5379
- Scientific domain
- Biotechnology; Medical oncology; Pharmacology drugs
- Publisher
- Pergamon Press, New York, NY
/
Pergamon Press, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Antioestrogène Chimiothérapie Essai clinique phase II Etude multicentrique Glande mammaire Homme Postménopause Stade avancé Torémifène Tumeur
- Keyword (en)
- Antineoplastic agent Antiestrogen Chemotherapy Phase II trial Multicenter study Mammary gland Human Postmenopause Advanced stage Tumor
- Keyword (es)
- Anticanceroso Antiestrógeno Quimioterapia Ensayo clínico fase II Estudio multicéntrico Glándula mamaria Hombre Postmenopausia Estadio avanzado Tumor
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 7677264
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/0277-5379(88)90316-1 
https://dx.doi.org/10.1016/0277-5379(88)90316-1
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/0277-5379(88)90316-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:98:\"Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer: phase II study\";s:9:\"\u0000*\u0000jtitle\";s:46:\"European journal of cancer & clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:26:\"Eur. j. cancer clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1988\";s:9:\"\u0000*\u0000volume\";s:2:\"24\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"785\";s:8:\"\u0000*\u0000epage\";s:3:\"790\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0277-5379\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"VALAVAARA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:11:\"PYRHONEN, S\";i:1;s:12:\"HEIKKINEN, M\";i:2;s:11:\"RISSANEN, P\";i:3;s:9:\"BLANCO, G\";i:4;s:9:\"THOLIX, E\";i:5;s:10:\"NORDMAN, E\";i:6;s:11:\"TASKINEN, P\";i:7;s:9:\"HOLSTI, L\";i:8;s:8:\"HAJBA, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"EJCODS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:98:\"Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer: phase II study\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:14:\"Pergamon Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/0277-5379(88)90316-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:98:\"Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer: phase II study\";s:9:\"\u0000*\u0000jtitle\";s:46:\"European journal of cancer & clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:26:\"Eur. j. cancer clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1988\";s:9:\"\u0000*\u0000volume\";s:2:\"24\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"785\";s:8:\"\u0000*\u0000epage\";s:3:\"790\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0277-5379\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"VALAVAARA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:11:\"PYRHONEN, S\";i:1;s:12:\"HEIKKINEN, M\";i:2;s:11:\"RISSANEN, P\";i:3;s:9:\"BLANCO, G\";i:4;s:9:\"THOLIX, E\";i:5;s:10:\"NORDMAN, E\";i:6;s:11:\"TASKINEN, P\";i:7;s:9:\"HOLSTI, L\";i:8;s:8:\"HAJBA, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"EJCODS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:98:\"Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer: phase II study\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:14:\"Pergamon Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/0277-5379(88)90316-1\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/0277-5379(88)90316-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:98:\"Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer: phase II study\";s:9:\"\u0000*\u0000jtitle\";s:46:\"European journal of cancer & clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:26:\"Eur. j. cancer clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1988\";s:9:\"\u0000*\u0000volume\";s:2:\"24\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"785\";s:8:\"\u0000*\u0000epage\";s:3:\"790\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0277-5379\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"VALAVAARA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:11:\"PYRHONEN, S\";i:1;s:12:\"HEIKKINEN, M\";i:2;s:11:\"RISSANEN, P\";i:3;s:9:\"BLANCO, G\";i:4;s:9:\"THOLIX, E\";i:5;s:10:\"NORDMAN, E\";i:6;s:11:\"TASKINEN, P\";i:7;s:9:\"HOLSTI, L\";i:8;s:8:\"HAJBA, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"EJCODS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:98:\"Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer: phase II study\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:14:\"Pergamon Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/0277-5379(88)90316-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:98:\"Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer: phase II study\";s:9:\"\u0000*\u0000jtitle\";s:46:\"European journal of cancer & clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:26:\"Eur. j. cancer clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1988\";s:9:\"\u0000*\u0000volume\";s:2:\"24\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"785\";s:8:\"\u0000*\u0000epage\";s:3:\"790\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0277-5379\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"VALAVAARA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:11:\"PYRHONEN, S\";i:1;s:12:\"HEIKKINEN, M\";i:2;s:11:\"RISSANEN, P\";i:3;s:9:\"BLANCO, G\";i:4;s:9:\"THOLIX, E\";i:5;s:10:\"NORDMAN, E\";i:6;s:11:\"TASKINEN, P\";i:7;s:9:\"HOLSTI, L\";i:8;s:8:\"HAJBA, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"EJCODS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:98:\"Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer: phase II study\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:14:\"Pergamon Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/0277-5379(88)90316-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:98:\"Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer: phase II study\";s:9:\"\u0000*\u0000jtitle\";s:46:\"European journal of cancer & clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:26:\"Eur. j. cancer clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1988\";s:9:\"\u0000*\u0000volume\";s:2:\"24\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"785\";s:8:\"\u0000*\u0000epage\";s:3:\"790\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0277-5379\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"VALAVAARA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:11:\"PYRHONEN, S\";i:1;s:12:\"HEIKKINEN, M\";i:2;s:11:\"RISSANEN, P\";i:3;s:9:\"BLANCO, G\";i:4;s:9:\"THOLIX, E\";i:5;s:10:\"NORDMAN, E\";i:6;s:11:\"TASKINEN, P\";i:7;s:9:\"HOLSTI, L\";i:8;s:8:\"HAJBA, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"EJCODS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:98:\"Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer: phase II study\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:14:\"Pergamon Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
